// App-Quantinova.ai

PB0632 : Doac-Remove™ Can Neutralize the Effect of Direct Oral Anticoagulants on Lupus Anticoagulant Assay: A Single-centre Experience

Researchers

Presenter

  • D. Velasco-Rodrguez

Principal Investigators

  • R. Vidal Laso

  • M. Lpez Prez

  • S. Martn Herrero

  • E. Jmnez Barral

  • A. Garca-Raso

  • R. de la Plaza

  • L.F. Lpez Romero

  • D. Mnguez

  • M.. Bueno

  • P. Llamas Sillero

Medical Centers

  • Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Venous thrombosis

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Evithrom

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved